Rate this post


— Written By Marne Coit

The FDA is holding a public hearing on May 31, 2019 from 8 a.m.–6 p.m. in Silver Spring, MD. In particular, the agency is considering information about safety concerns related to CBD, including dosage, mode of delivery and how CBD interacts with medications. More information about this hearing and instructions for submitting written comments can be found in the Federal Register.

The hearing will also be webcast. Instructions on how to access the webcast can be found here.